Management
Vilasack Thammavongsa, Ph.D.
Chief Executive Officer and Director of Research
Chief Executive Officer and Director of Research
Dr. Thammavongsa is an immunologist and biotechnology entrepreneur specializing in microbial pathogenesis and immune-based prevention of bacterial disease. He received his Ph.D. in Immunology from the University of Michigan and completed postdoctoral training in bacterial pathogenesis at the University of Chicago. His work centers on translating insights into host–pathogen interactions into next-generation vaccine and antibody therapies. Originally from Laos, he is committed to advancing innovative solutions to address urgent global infectious disease challenges.
Dominique Missiakas, Ph.D.
Founder and Chief Scientific Officer
Founder and Chief Scientific Officer
Dominique Missiakas was born in France and received her PhD degree from the Université Paris XI. She is a Professor at the University of Chicago in the Department of Microbiology and Director of the Howard Taylor Ricketts Laboratory at Argonne National Laboratory. For more than 20 years, Dr. Missiakas has been engaged in scientific research and teaching at first-class universities in Europe and in the United States. Dr. Missiakas has carried out extensive research in bacterial genetics and physiology, bacterial pathogenesis, molecular biology and animal models for the study of disease and the development of vaccines or therapeutics. Dr. Missiakas has published more than 100 peer-reviewed manuscripts, and has been awarded more than fifteen patents. Dr. Missiakas’ research elucidated the molecular underpinnings of staphylococcal coagulation and escape from host phagocytic killing.
Hwan Keun Kim, Ph.D.
Scientific advisor
Scientific advisor
A native of South Korea, Hwan Keun Kim received his Ph.D. and postdoctoral studies in microbiology from the University of Chicago where he elucidated the molecular biology of staphylococcal immune evasion and B cell suppression. He is an assistant professor in The Renaissance School of Medicine at Stony Brook University focusing his studies on Rickettsia caused human diseases. He is an expert in the development of animal models for infectious diseases as well as in the analysis of vaccine antigens and antibody development.
Advisory board
To be Announced
To be Announced
